Bio-Rad Laboratories BIO
NYSE BIO
$376.69 +12.43 (+3.41%)
At close: Aug 20, 2026 · 1:24 PM UTC

Bio-Rad Laboratories (BIO) Return on Invested Capital (QoQ) (2010 - 2026)

Bio-Rad Laboratories (BIO) Return on Invested Capital (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.81 Bn 193.21 Bn 7.27 Bn
2 Stryker 127.76 Bn 124.28 Bn 4.50 Bn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn
4 Boston Scientific 73.25 Bn 72.71 Bn 3.85 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn
6 Dexcom 34.43 Bn 32.49 Bn 830.00 Mn
7 GE HealthCare Technologies 33.88 Bn 31.77 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.11 Bn 22.63 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.07 Bn 8.46 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 -7.00
Dec 31, 2025 -29.00
Sep 30, 2025 1.00
Jun 30, 2025 -17.00
Mar 31, 2025 -17.00
Dec 31, 2024 -33.00
Sep 30, 2024 -30.00
Jun 30, 2024 12.00
Mar 31, 2024 -11.00
Dec 31, 2023 -30.00
Sep 30, 2023 5.00
Jun 30, 2023 -6.00
Mar 31, 2023 -36.00
Dec 31, 2022 51.00
Sep 30, 2022 40.00
Jun 30, 2022 61.00
Mar 31, 2022 14.00
Dec 31, 2021 29.00
Sep 30, 2021 1.00